Cardiovascular Drug-Eluting Stents(DES) - Global and China Top Players Market Share and Ranking 2023
According to Research, the global market for Cardiovascular Drug-Eluting Stents(DES) should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Cardiovascular Drug-Eluting Stents(DES) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Cardiovascular Drug-Eluting Stents(DES) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects
This report studies and analyses global Cardiovascular Drug-Eluting Stents(DES) status and future trends, helps the client to determine the Cardiovascular Drug-Eluting Stents(DES) market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Cardiovascular Drug-Eluting Stents(DES), and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Cardiovascular Drug-Eluting Stents(DES) market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Cardiovascular Drug-Eluting Stents(DES) sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Cardiovascular Drug-Eluting Stents(DES) sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Cardiovascular Drug-Eluting Stents(DES) key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Cardiovascular Drug-Eluting Stents(DES) key producing regions, capacity, production, and year over year growth
(6) Cardiovascular Drug-Eluting Stents(DES) industry chains, upstream, midstream and downstream
Market segment by players, this report covers
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Boston Scientific
MicroPort Medical
Market segment by Type, covers
Passive Coating
Active Coating
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Cardiovascular Drug-Eluting Stents(DES) product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Cardiovascular Drug-Eluting Stents(DES) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Cardiovascular Drug-Eluting Stents(DES) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Cardiovascular Drug-Eluting Stents(DES), percent & CAGR, 2018-2029
Chapter 5: Cardiovascular Drug-Eluting Stents(DES) industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Cardiovascular Drug-Eluting Stents(DES) Definition
1.2 Global Cardiovascular Drug-Eluting Stents(DES) Market Size and Forecast
1.2.1 By Consumption Value, Global Cardiovascular Drug-Eluting Stents(DES) Market Size，2018-2029
1.2.2 By Sales Quantity, Global Cardiovascular Drug-Eluting Stents(DES) Market Size，2018-2029
1.2.3 Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP)，2018-2029
1.3 China Cardiovascular Drug-Eluting Stents(DES) Market Size and Forecast
1.3.1 By Consumption Value, China Cardiovascular Drug-Eluting Stents(DES) Market Size，2018-2029
1.3.2 By Sales Quantity, China Cardiovascular Drug-Eluting Stents(DES) Market Size，2018-2029
1.3.3 China Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP)， 2018-2029
1.4 Share of China Cardiovascular Drug-Eluting Stents(DES) Market with Respect to the Global Market
1.4.1 By Consumption Value, China Cardiovascular Drug-Eluting Stents(DES) Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Cardiovascular Drug-Eluting Stents(DES) Market Share in Global, 2018-2029
1.4.3 Cardiovascular Drug-Eluting Stents(DES) Market Size: China VS Global, 2018-2029
1.5 Cardiovascular Drug-Eluting Stents(DES) Market Dynamics
1.5.1 Cardiovascular Drug-Eluting Stents(DES) Market Drivers
1.5.2 Cardiovascular Drug-Eluting Stents(DES) Market Restraints
1.5.3 Cardiovascular Drug-Eluting Stents(DES) Industry Trends
1.5.4 Cardiovascular Drug-Eluting Stents(DES) Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Cardiovascular Drug-Eluting Stents(DES), Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Cardiovascular Drug-Eluting Stents(DES), Global Market Share by Company, 2018-2023
2.3 Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Cardiovascular Drug-Eluting Stents(DES) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Cardiovascular Drug-Eluting Stents(DES) Concentration Ratio
2.6 Global Cardiovascular Drug-Eluting Stents(DES) Mergers & Acquisitions, Expansion Plans
2.7 Global Cardiovascular Drug-Eluting Stents(DES) Manufacturers Product Type
2.8 Head Office and Cardiovascular Drug-Eluting Stents(DES) Production Site of Key Manufacturer
2.9 Cardiovascular Drug-Eluting Stents(DES) Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Cardiovascular Drug-Eluting Stents(DES), China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Cardiovascular Drug-Eluting Stents(DES), China Market Share by Company, 2018-2023
3.3 China Cardiovascular Drug-Eluting Stents(DES) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Cardiovascular Drug-Eluting Stents(DES) Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Cardiovascular Drug-Eluting Stents(DES) Capacity by Region
4.3 Global Cardiovascular Drug-Eluting Stents(DES) Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Cardiovascular Drug-Eluting Stents(DES) Production by Region, 2018-2029
4.5 Global Cardiovascular Drug-Eluting Stents(DES) Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Cardiovascular Drug-Eluting Stents(DES) Industry Chain
5.2 Cardiovascular Drug-Eluting Stents(DES) Upstream Analysis
5.2.1 Cardiovascular Drug-Eluting Stents(DES) Core Raw Materials
5.2.2 Main Manufacturers of Cardiovascular Drug-Eluting Stents(DES) Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Cardiovascular Drug-Eluting Stents(DES) Production Mode
5.6 Cardiovascular Drug-Eluting Stents(DES) Procurement Model
5.7 Cardiovascular Drug-Eluting Stents(DES) Industry Sales Model and Sales Channels
5.7.1 Cardiovascular Drug-Eluting Stents(DES) Sales Model
5.7.2 Cardiovascular Drug-Eluting Stents(DES) Typical Distributors
6 Sights by Type
6.1 Cardiovascular Drug-Eluting Stents(DES) Classification
6.1.1 Passive Coating
6.1.2 Active Coating
6.2 By Type, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029
6.4 By Type, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029
6.5 By Type, Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Cardiovascular Drug-Eluting Stents(DES) Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029
7.4 By Application, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029
7.5 By Application, Global Cardiovascular Drug-Eluting Stents(DES) Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029
8.3 By Region, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Cardiovascular Drug-Eluting Stents(DES) & Forecasts, 2018-2029
8.4.2 By Country, North America Cardiovascular Drug-Eluting Stents(DES) Market Size Market Share
8.5 Europe
8.5.1 Europe Cardiovascular Drug-Eluting Stents(DES) Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Cardiovascular Drug-Eluting Stents(DES) Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Cardiovascular Drug-Eluting Stents(DES) Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Cardiovascular Drug-Eluting Stents(DES) Market Size Market Share
8.7 South America
8.7.1 South America Cardiovascular Drug-Eluting Stents(DES) Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Cardiovascular Drug-Eluting Stents(DES) Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Cardiovascular Drug-Eluting Stents(DES) Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029
9.3 By Country, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Cardiovascular Drug-Eluting Stents(DES) Market Size, 2018-2029
9.4.2 By Type, U.S. Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Cardiovascular Drug-Eluting Stents(DES) Market Size, 2018-2029
9.5.2 By Type, Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Cardiovascular Drug-Eluting Stents(DES) Market Size, 2018-2029
9.6.2 By Type, China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Cardiovascular Drug-Eluting Stents(DES) Market Size, 2018-2029
9.7.2 By Type, Japan Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Cardiovascular Drug-Eluting Stents(DES) Market Size, 2018-2029
9.8.2 By Type, South Korea Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Cardiovascular Drug-Eluting Stents(DES) Market Size, 2018-2029
9.10.2 By Type, India Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 MIV Therapeutics
10.1.1 MIV Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.1.2 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.1.3 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 MIV Therapeutics Company Profile and Main Business
10.1.5 MIV Therapeutics Recent Developments
10.2 Orbusneich
10.2.1 Orbusneich Company Information, Head Office, Market Area, and Industry Position
10.2.2 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.2.3 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Orbusneich Company Profile and Main Business
10.2.5 Orbusneich Recent Developments
10.3 Promed Medical
10.3.1 Promed Medical Company Information, Head Office, Market Area, and Industry Position
10.3.2 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.3.3 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Promed Medical Company Profile and Main Business
10.3.5 Promed Medical Recent Developments
10.4 Relisys Medical
10.4.1 Relisys Medical Company Information, Head Office, Market Area, and Industry Position
10.4.2 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.4.3 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Relisys Medical Company Profile and Main Business
10.4.5 Relisys Medical Recent Developments
10.5 Reva Medical
10.5.1 Reva Medical Company Information, Head Office, Market Area, and Industry Position
10.5.2 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.5.3 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Reva Medical Company Profile and Main Business
10.5.5 Reva Medical Recent Developments
10.6 Sahajanand
10.6.1 Sahajanand Company Information, Head Office, Market Area, and Industry Position
10.6.2 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.6.3 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sahajanand Company Profile and Main Business
10.6.5 Sahajanand Recent Developments
10.7 Sino Medical
10.7.1 Sino Medical Company Information, Head Office, Market Area, and Industry Position
10.7.2 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.7.3 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Sino Medical Company Profile and Main Business
10.7.5 Sino Medical Recent Developments
10.8 Sorin
10.8.1 Sorin Company Information, Head Office, Market Area, and Industry Position
10.8.2 Sorin Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.8.3 Sorin Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Sorin Company Profile and Main Business
10.8.5 Sorin Recent Developments
10.9 Terumo Medical
10.9.1 Terumo Medical Company Information, Head Office, Market Area, and Industry Position
10.9.2 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.9.3 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Terumo Medical Company Profile and Main Business
10.9.5 Terumo Medical Recent Developments
10.10 Abbott Vascular
10.10.1 Abbott Vascular Company Information, Head Office, Market Area, and Industry Position
10.10.2 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.10.3 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Abbott Vascular Company Profile and Main Business
10.10.5 Abbott Vascular Recent Developments
10.11 Advantec Vascular
10.11.1 Advantec Vascular Company Information, Head Office, Market Area, and Industry Position
10.11.2 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.11.3 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Advantec Vascular Company Profile and Main Business
10.11.5 Advantec Vascular Recent Developments
10.12 B.Braun Melsengen AG
10.12.1 B.Braun Melsengen AG Company Information, Head Office, Market Area, and Industry Position
10.12.2 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.12.3 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 B.Braun Melsengen AG Company Profile and Main Business
10.12.5 B.Braun Melsengen AG Recent Developments
10.13 Biosensors
10.13.1 Biosensors Company Information, Head Office, Market Area, and Industry Position
10.13.2 Biosensors Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.13.3 Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Biosensors Company Profile and Main Business
10.13.5 Biosensors Recent Developments
10.14 Boston Scientific
10.14.1 Boston Scientific Company Information, Head Office, Market Area, and Industry Position
10.14.2 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.14.3 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Boston Scientific Company Profile and Main Business
10.14.5 Boston Scientific Recent Developments
10.15 MicroPort Medical
10.15.1 MicroPort Medical Company Information, Head Office, Market Area, and Industry Position
10.15.2 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
10.15.3 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 MicroPort Medical Company Profile and Main Business
10.15.5 MicroPort Medical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Cardiovascular Drug-Eluting Stents(DES) Market Restraints
Table 3. Cardiovascular Drug-Eluting Stents(DES) Market Trends
Table 4. Cardiovascular Drug-Eluting Stents(DES) Industry Policy
Table 5. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Cardiovascular Drug-Eluting Stents(DES) Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Cardiovascular Drug-Eluting Stents(DES) Mergers & Acquisitions, Expansion Plans
Table 12. Global Cardiovascular Drug-Eluting Stents(DES) Manufacturers Product Type
Table 13. Head Office and Cardiovascular Drug-Eluting Stents(DES) Production Site of Key Manufacturer
Table 14. Cardiovascular Drug-Eluting Stents(DES) Capacity of Major Manufacturers and Future Plan
Table 15. China Cardiovascular Drug-Eluting Stents(DES) Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Cardiovascular Drug-Eluting Stents(DES) Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Cardiovascular Drug-Eluting Stents(DES) Production by Region, 2018-2023, (K Units)
Table 20. Global Cardiovascular Drug-Eluting Stents(DES) Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Cardiovascular Drug-Eluting Stents(DES) Upstream (Raw Materials)
Table 22. Global Cardiovascular Drug-Eluting Stents(DES) Typical Customers
Table 23. Cardiovascular Drug-Eluting Stents(DES) Typical Distributors
Table 24. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2018-2029
Table 34. MIV Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 35. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 36. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. MIV Therapeutics Company Profile and Main Business
Table 38. MIV Therapeutics Recent Developments
Table 39. Orbusneich Company Information, Head Office, Market Area, and Industry Position
Table 40. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 41. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Orbusneich Company Profile and Main Business
Table 43. Orbusneich Recent Developments
Table 44. Promed Medical Company Information, Head Office, Market Area, and Industry Position
Table 45. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 46. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Promed Medical Company Profile and Main Business
Table 48. Promed Medical Recent Developments
Table 49. Relisys Medical Company Information, Head Office, Market Area, and Industry Position
Table 50. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 51. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Relisys Medical Company Profile and Main Business
Table 53. Relisys Medical Recent Developments
Table 54. Reva Medical Company Information, Head Office, Market Area, and Industry Position
Table 55. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 56. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Reva Medical Company Profile and Main Business
Table 58. Reva Medical Recent Developments
Table 59. Sahajanand Company Information, Head Office, Market Area, and Industry Position
Table 60. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 61. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Sahajanand Company Profile and Main Business
Table 63. Sahajanand Recent Developments
Table 64. Sino Medical Company Information, Head Office, Market Area, and Industry Position
Table 65. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 66. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Sino Medical Company Profile and Main Business
Table 68. Sino Medical Recent Developments
Table 69. Sorin Company Information, Head Office, Market Area, and Industry Position
Table 70. Sorin Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 71. Sorin Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Sorin Company Profile and Main Business
Table 73. Sorin Recent Developments
Table 74. Terumo Medical Company Information, Head Office, Market Area, and Industry Position
Table 75. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 76. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Terumo Medical Company Profile and Main Business
Table 78. Terumo Medical Recent Developments
Table 79. Abbott Vascular Company Information, Head Office, Market Area, and Industry Position
Table 80. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 81. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Abbott Vascular Company Profile and Main Business
Table 83. Abbott Vascular Recent Developments
Table 84. Advantec Vascular Company Information, Head Office, Market Area, and Industry Position
Table 85. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 86. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Advantec Vascular Company Profile and Main Business
Table 88. Advantec Vascular Recent Developments
Table 89. B.Braun Melsengen AG Company Information, Head Office, Market Area, and Industry Position
Table 90. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 91. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. B.Braun Melsengen AG Company Profile and Main Business
Table 93. B.Braun Melsengen AG Recent Developments
Table 94. Biosensors Company Information, Head Office, Market Area, and Industry Position
Table 95. Biosensors Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 96. Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Biosensors Company Profile and Main Business
Table 98. Biosensors Recent Developments
Table 99. Boston Scientific Company Information, Head Office, Market Area, and Industry Position
Table 100. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 101. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Boston Scientific Company Profile and Main Business
Table 103. Boston Scientific Recent Developments
Table 104. MicroPort Medical Company Information, Head Office, Market Area, and Industry Position
Table 105. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application
Table 106. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. MicroPort Medical Company Profile and Main Business
Table 108. MicroPort Medical Recent Developments
List of Figures
Figure 1. Cardiovascular Drug-Eluting Stents(DES) Picture
Figure 2. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Cardiovascular Drug-Eluting Stents(DES) Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units) & (2018-2029)
Figure 7. China Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Cardiovascular Drug-Eluting Stents(DES) Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Cardiovascular Drug-Eluting Stents(DES) Market Share of Global, 2018-2029
Figure 10. Global Cardiovascular Drug-Eluting Stents(DES) Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Cardiovascular Drug-Eluting Stents(DES) Key Participants, Market Share, 2022
Figure 12. Global Cardiovascular Drug-Eluting Stents(DES) Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Cardiovascular Drug-Eluting Stents(DES) Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Cardiovascular Drug-Eluting Stents(DES) Production Market Share & Forecast by Region, 2018-2029
Figure 15. Cardiovascular Drug-Eluting Stents(DES) Industry Chain
Figure 16. Cardiovascular Drug-Eluting Stents(DES) Procurement Model
Figure 17. Cardiovascular Drug-Eluting Stents(DES) Sales Model
Figure 18. Cardiovascular Drug-Eluting Stents(DES) Sales Channels, Direct Sales, and Distribution
Figure 19. Passive Coating
Figure 20. Active Coating
Figure 21. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospital
Figure 27. Clinic
Figure 28. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029, US$ Million
Figure 29. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2018-2029
Figure 30. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 31. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2018-2029
Figure 32. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 33. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2018-2029
Figure 34. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2018-2029
Figure 35. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 36. By Country, North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2022
Figure 37. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2022
Figure 39. Asia Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country/Region, Asia Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2022
Figure 41. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2022
Figure 43. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. U.S. Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 45. By Type, U.S. Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 46. By Application, U.S. Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 47. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 50. China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 53. Japan Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Japan Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Japan Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 56. South Korea Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, South Korea Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, South Korea Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 59. Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 62. India Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, India Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, India Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 65. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up and Top-down Approaches
Figure 71. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|